X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (277) 277
humans (263) 263
atrial fibrillation (226) 226
male (119) 119
female (118) 118
stroke (96) 96
risk factors (84) 84
management (82) 82
electrocardiography (75) 75
animals (74) 74
aged (73) 73
middle aged (72) 72
guidelines (71) 71
anticoagulation (69) 69
catheter ablation (64) 64
treatment outcome (63) 63
cardiac arrhythmia (62) 62
cardiology (60) 60
atrial fibrillation - diagnosis (59) 59
atrial fibrillation - therapy (59) 59
atrial fibrillation - drug therapy (56) 56
atrial fibrillation - complications (53) 53
heart failure (53) 53
cardiovascular (48) 48
stroke - prevention & control (48) 48
arrhythmias (47) 47
medicin och hälsovetenskap (46) 46
abridged index medicus (45) 45
medical and health sciences (45) 45
heart (43) 43
atrial fibrillation - physiopathology (42) 42
mice (42) 42
warfarin (41) 41
fibrillation (40) 40
adult (39) 39
europe (39) 39
prospective studies (39) 39
clinical medicine (37) 37
time factors (37) 37
anticoagulants (36) 36
prevention (36) 36
rhythm control (36) 36
aged, 80 and over (35) 35
anti-arrhythmia agents - therapeutic use (35) 35
risk assessment (35) 35
arrhythmia (33) 33
kardiologi (33) 33
mortality (33) 33
research (33) 33
anticoagulants - therapeutic use (32) 32
rate control (32) 32
risk (32) 32
bleeding (31) 31
prognosis (31) 31
atrial fibrillation - epidemiology (30) 30
follow-up (30) 30
klinisk medicin (30) 30
cardiac and cardiovascular systems (29) 29
electrophysiology (29) 29
acute myocardial-infarction (28) 28
peripheral vascular disease (28) 28
analysis (27) 27
care and treatment (27) 27
anticoagulants - administration & dosage (26) 26
heart-failure (26) 26
antiarrhythmic drugs (25) 25
atrial-fibrillation (25) 25
european-society (25) 25
practice guidelines as topic (25) 25
prevalence (25) 25
stroke - etiology (25) 25
ablation (24) 24
cardioversion (24) 24
radiofrequency catheter ablation (24) 24
registries (24) 24
stroke prevention (24) 24
administration, oral (23) 23
oral anticoagulation (23) 23
quality-of-life (23) 23
repolarization (23) 23
therapy (23) 23
cardiomyopathy (22) 22
catheter ablation - methods (22) 22
clinical trials (22) 22
hemorrhage - chemically induced (22) 22
patients (21) 21
registry (21) 21
task-force (21) 21
medicine, general & internal (20) 20
mice, transgenic (20) 20
rivaroxaban (20) 20
sudden cardiac death (20) 20
anticoagulants - adverse effects (19) 19
antithrombotic therapy (19) 19
diagnosis (19) 19
follow-up studies (19) 19
hypertension (19) 19
pulmonary vein isolation (19) 19
transient ischemic attack (19) 19
arrhythmias, cardiac - therapy (18) 18
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (700) 700
German (38) 38
Spanish (8) 8
French (6) 6
Italian (4) 4
Russian (4) 4
Polish (3) 3
Romanian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Heart, ISSN 1355-6037, 05/2017, Volume 103, Issue 10, pp. 729 - 731
  [...]there is a clear need for further research into the causes of AF, into better ways to prevent AF, the role of rhythm and rate control therapy for... 
Stroke | STROKE | MORTALITY | TRIAL | BENEFIT | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | WARFARIN | RISK | ABLATION | Atrial fibrillation | Patient outcomes | Analysis | Practice guidelines (Medicine) | Anticoagulants (Medicine) | Dosage and administration | Research | Diagnosis | Cardiac arrhythmia | Credit unions | Catheters | 1506
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2014, Volume 384, Issue 9961, pp. 2235 - 2243
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10035, pp. 2266 - 2268
Journal Article
The American heart journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 68, Issue 17, pp. 1881 - 1894
Abstract Background Antiarrhythmic drugs are widely used to treat patients with atrial fibrillation (AF), but the mechanisms conveying their variable... 
Cardiovascular | Internal Medicine | drug targets | antiarrhythmic drugs | atrial fibrillation | electrophysiology | personalized medicine | rhythm control | POST-REPOLARIZATION REFRACTORINESS | FIBRILLATION | POSTREPOLARIZATION REFRACTORINESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANISMS | EXPERIMENTAL-MODEL | PLEXUS ABLATION | RANOLAZINE | TASK-1 | DRONEDARONE | K+ CHANNEL | Transcription Factors - physiology | Atrial Fibrillation - drug therapy | Anti-Arrhythmia Agents - pharmacology | Humans | Middle Aged | Gene Expression Regulation | Male | Transcription Factors - genetics | Atrial Fibrillation - physiopathology | Membrane Potentials - physiology | Homeodomain Proteins - genetics | Animals | Voltage-Gated Sodium Channel Blockers - therapeutic use | Adult | Female | Aged | Mice | Electrophysiological Phenomena | Heart Atria - physiopathology | Homeodomain Proteins - physiology | Flecainide - therapeutic use | Heart | Medical colleges | Hospitals | Atrial fibrillation | Anti-arrhythmia drugs | Cardiology | Gene expression | Pharmaceutical industry | Electric properties | Cardiac arrhythmia | Transcription factors | Sodium | Velocity | Rodents | Deoxyribonucleic acid--DNA | LAA, left atrial appendage | PITX2, paired like homeodomain-2 | APD, action potential duration | ERP, effective refractory period | LA, left atrium | TASK-2, TWIK-related acid-sensitive K+ channel | RMP, resting membrane potential | HEK, human embryonic kidney | Na, sodium | SNP, single nucleotide polymorphism | PRR, post-repolarization refractoriness | mRNA, messenger ribonucleic acid | Original Investigation | AAD, antiarrhythmic drug
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 1, pp. 10 - 12
Corresponding Author 
Cardiovascular | Internal Medicine | Cardiology
Journal Article